Shape-Changing IOL Shows Durability

Atia Vision reports positive 36-month data for its shape-changing IOL at ASCRS 2026

April 28, 2026
3 min

The Ophthalmologist

Objective:

To present three-year first-in-human data for the investigational OmniVu Lens System, emphasizing its investigational status and evaluating its refractive stability and visual outcomes.

Approach:

Key Findings:

Mean manifest refraction spherical equivalent remained within ±0.50 D over three years.
Mean binocular uncorrected distance visual acuity at 36 months was -0.11 logMAR (approximately 20/16), with best-corrected distance acuity of -0.17 logMAR (about 20/12).
Mean uncorrected near acuity reached 0.06 logMAR (roughly 20/25).
Defocus testing showed 20/32 or better vision across around 5.0 D of continuous defocus.
Only one YAG capsulotomy reported with no lens exchanges or refractive enhancements required.
Contrast sensitivity data comparable to published monofocal IOL benchmarks.

Interpretation:

The OmniVu Lens System demonstrates sustained refractive stability and a broad functional range of vision, suggesting potential advantages in premium cataract surgery, particularly in presbyopia correction.

Limitations:

The device is still investigational and not approved for sale, limiting generalizability.
Limited sample size of 19 patients.

Conclusion:

The durability of outcomes from the OmniVu Lens System indicates a promising future for shape-changing, modular designs in presbyopia correction, potentially impacting the landscape of premium cataract surgery.